08 May 2024 - the European Medicines Agency (EMA) announced the withdrawal of the authorisation for AstraZeneca's Vaxzevria at the request of the marketing authorisation holder. The EMA had initially approved AstraZeneca's COVID-19 vaccine in January 2021. However, concerns about its safety arose when several countries suspended its use due to blood clots in vaccinated individuals.

The Financial Times reports that the pay of the FTSE 100 chief executives has hit an average of almost £5mn after an increase of £560,000 last year. AstraZeneca boss Sir Pascal Soriot remained the best paid, with £16.9mn.